6.85
Kyntra Bio Inc Aktie (KYNB) Neueste Nachrichten
KYNB Stock Price, Quote & Chart | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill
KYNB Technical Analysis | Trend, Signals & Chart Patterns | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill
Kyntra Bio CEO Thane Wettig buys $19,852 in stock - Investing.com India
Kyntra Bio CEO Thane Wettig buys $19,852 in stock By Investing.com - Investing.com Australia
KYNTRA BIO (KYNB) CEO Thane Wettig adds 2,800 shares in open-market buy - Stock Titan
What's Next for Kyntra Bio (KYNB) at $6.80? 2026-05-19Growth Picks - Newser
Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale - TipRanks
Kyntra Bio CEO Thane Wettig buys $19,852 in company stock By Investing.com - Investing.com Australia
Kyntra Bio CEO Thane Wettig buys $19,852 in company stock - Investing.com India
KYNTRA BIO (KYNB) CEO Thane Wettig purchases 2,800 shares at $7.09 - Stock Titan
Kyntra Bio (KYNB) Q1 2026 Earnings Transcript - AOL.com
Armistice Capital (FGEN) reports 400,000-share, 9.88% position (May 2026) - Stock Titan
Kyntra Bio (KYNB) Institutional Ownership 2026 - MarketBeat
Number of shareholders of Kyntra Bio, Inc. – NASDAQ:KYNB - TradingView
Number of shareholders of Kyntra Bio, Inc. – LSE:0IL8 - TradingView
Kyntra Bio (Nasdaq: KYNB) Q1 2026 results show higher revenue, ongoing R&D spend - Stock Titan
Kyntra Bio stock (US3156631046): Q1 2026 revenue rises to $3.7M amid pipeline advances - AD HOC NEWS
Kyntra Bio Inc. (KYNB) News, Articles, Events & Latest Updates - Stocktwits
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances Amidst Challenges - GuruFocus
Kyntra Bio targets Q4 2026 interim readout while extending cash runway into 2028 - MSN
Kyntra Bio (KYNB) reports Q1 loss, tops revenue estimates - MSN
Kyntra Bio, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:KYNB) 2026-05-11 - Seeking Alpha
KYNB: Revenue rose, expenses fell, and clinical milestones remain on track with cash runway into 2028 - TradingView
Is Kyntra Bio (KYNB) 31.3% Overvalued After Q1 2026 Earnings Bea - GuruFocus
KYNB: Revenue up, losses narrowed, and key clinical programs advancing with strong cash position - TradingView
Kyntra Bio (KYNB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Kyntra Bio (NASDAQ:KYNB) Q1 Revenue Surges 180% as EPS Miss Tempers After-Hours Gains - ChartMill
Kyntra Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Kyntra Bio: Q1 Earnings Snapshot - 10TV
Kyntra Bio : Reports First Quarter 2026 Financial Results - marketscreener.com
KYNB: Q1 2026 revenue rose to $3.7M, net loss narrowed, and key clinical trials advanced - TradingView
Kyntra Bio (NASDAQ: FGEN) Q1 2026 results, oncology pipeline and cash runway - Stock Titan
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update - Yahoo! Finance Canada
MSN Money - MSN
Kyntra Bio Inc (KYNB) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic Advances ... By GuruFocus - Investing.com Canada
Kyntra Bio Inc expected to post a loss of $3.35 a shareEarnings Preview - TradingView
Kyntra Bio (KYNB) upgraded to buy: Here's what you should know - MSN
Earnings Preview: Kyntra Bio to Report Financial Results Post-market on May 11 - 富途牛牛
Kyntra Bio sets May 11 Q1 results release, 5 p.m. investor call - Stock Titan
Kyntra Bio to Report First Quarter 2026 Financial Results - GlobeNewswire
Kyntra Bio to report Q1 2026 financial results and host investor call on May 11 - Pluang
William Blair Maintains KYNTRA BIO INC(KYNB.US) With Hold Rating - 富途牛牛
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):